AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO (aztreonam and avibactam), as a ...

AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

Carbapenem-resistant Enterobacterales (CRE), including carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant ...

NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the ...

Researchers have used artificial intelligence to identify 25 new protein compounds that can kill bacteria and fungi, ...

The epidemiologic characteristics of Mycoplasma pneumoniae infection, including cyclic epidemics and age distribution in epidemics, differ among populations and may change within a population.

Hello, everyone, and welcome to the Iterum Therapeutics PLC Fourth-Quarter and Full Year 2024 Financial Results. My name is Ezra, and I will be your coordinator today. (Operator Instructions) I will ...

Twenty-three European nations have seen a rise in carbapenem-resistant Klebsiella pneumoniae bloodstream infections since ...